Rolf C R Ljung

Summary

Affiliation: Lund University
Country: Sweden

Publications

  1. doi request reprint 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors
    R Ljung
    Department of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Lund University, Skane University Hospital, Malmo, Sweden
    J Thromb Haemost 11:1260-8. 2013
  2. doi request reprint Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
    R Ljung
    Department of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Lund University, Skane University Hospital, Malmo, Sweden
    Haemophilia 19:481-6. 2013
  3. doi request reprint Hemophilia and prophylaxis
    Rolf Ljung
    Departments of Pediatrics, Malmö and Lund and Malmö Centre for Thrombosis and Haemostasis, Skane University Hospital, Lund University, Malmo, Sweden
    Pediatr Blood Cancer 60:S23-6. 2013
  4. doi request reprint How to manage invasive procedures in children with haemophilia
    Rolf C R Ljung
    Lund University, Departments of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Skane University Hospital, Sweden
    Br J Haematol 157:519-28. 2012
  5. ncbi request reprint Intracranial haemorrhage in haemophilia A and B
    Rolf C R Ljung
    Department of Paediatrics, Lund University, University Hospital, Malmo, Sweden
    Br J Haematol 140:378-84. 2008
  6. doi request reprint Haemophilia in the first years of life
    R Ljung
    Departments of Paediatric, Lund University, University Hospital, Malmo, Sweden
    Haemophilia 14:188-95. 2008
  7. doi request reprint Prophylactic therapy in haemophilia
    Rolf Ljung
    Departments of Paediatrics and Coagulation Disorders, Lund University, University Hospital, Malmo, Sweden
    Blood Rev 23:267-74. 2009
  8. doi request reprint The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery
    R Ljung
    Departments of Paediatrics and Coagulation Disorders, Lund University, University Hospital, Malmo, Sweden
    Haemophilia 16:415-9. 2010
  9. ncbi request reprint Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B
    Karin E Knobe
    Department of Pediatrics, Lund University, University Hospital, Malmo, Sweden
    Pathophysiol Haemost Thromb 35:370-5. 2006

Detail Information

Publications9

  1. doi request reprint 40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors
    R Ljung
    Department of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Lund University, Skane University Hospital, Malmo, Sweden
    J Thromb Haemost 11:1260-8. 2013
    ....
  2. doi request reprint Novel coagulation factor concentrates: issues relating to their clinical implementation and pharmacokinetic assessment for optimal prophylaxis in haemophilia patients
    R Ljung
    Department of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Lund University, Skane University Hospital, Malmo, Sweden
    Haemophilia 19:481-6. 2013
    ..Finally, as treatment adherence may be more important to ensure that a therapeutic level of a new coagulation factor concentrate is maintained, behavioural techniques could be implemented to help to improve treatment adherence...
  3. doi request reprint Hemophilia and prophylaxis
    Rolf Ljung
    Departments of Pediatrics, Malmö and Lund and Malmö Centre for Thrombosis and Haemostasis, Skane University Hospital, Lund University, Malmo, Sweden
    Pediatr Blood Cancer 60:S23-6. 2013
    ..This review covers proof of concept of primary prophylaxis in children, comparisons between prophylaxis and on demand treatment, and future trends of prophylactic treatment of hemophilia...
  4. doi request reprint How to manage invasive procedures in children with haemophilia
    Rolf C R Ljung
    Lund University, Departments of Paediatrics and Malmö Centre for Thrombosis and Haemostasis, Skane University Hospital, Sweden
    Br J Haematol 157:519-28. 2012
    ....
  5. ncbi request reprint Intracranial haemorrhage in haemophilia A and B
    Rolf C R Ljung
    Department of Paediatrics, Lund University, University Hospital, Malmo, Sweden
    Br J Haematol 140:378-84. 2008
    ..Some studies have reported a substantial proportion of ICH affecting patients with milder forms of haemophilia. The risk of ICH has to be considered when discussing treatment strategies for haemophilia patients...
  6. doi request reprint Haemophilia in the first years of life
    R Ljung
    Departments of Paediatric, Lund University, University Hospital, Malmo, Sweden
    Haemophilia 14:188-95. 2008
    ....
  7. doi request reprint Prophylactic therapy in haemophilia
    Rolf Ljung
    Departments of Paediatrics and Coagulation Disorders, Lund University, University Hospital, Malmo, Sweden
    Blood Rev 23:267-74. 2009
    ....
  8. doi request reprint The optimal mode of delivery for the haemophilia carrier expecting an affected infant is vaginal delivery
    R Ljung
    Departments of Paediatrics and Coagulation Disorders, Lund University, University Hospital, Malmo, Sweden
    Haemophilia 16:415-9. 2010
    ..Instrumental delivery such as use of vacuum extraction and foetal scalp monitors must be avoided at delivery of carriers...
  9. ncbi request reprint Functional analysis of the factor IX epidermal growth factor-like domain mutation Ile66Thr associated with mild hemophilia B
    Karin E Knobe
    Department of Pediatrics, Lund University, University Hospital, Malmo, Sweden
    Pathophysiol Haemost Thromb 35:370-5. 2006
    ..However, the ability of FIX Ile66Thr to activate FX was impaired in both the presence and absence of FVIIIa, indicating that Ile66 is not directly involved in the binding of FIX to FVIIIa...